Antiviral Research

Papers
(The H4-Index of Antiviral Research is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Metformin inhibits EV-A71 and CVA16 infections by regulating TRIB3-SCARB2 axis and activating AMPK352
M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings97
25R,26-hydroxycholesterol and an oxysterol synthetic analog inhibit Varicella zoster Virus replication90
Editorial Board75
Serum O-glycosylated HBsAg levels correlate with HBV RNA in HBeAg positive CHB patients during antiviral therapy58
Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection58
Seeking innovative concepts in development of antiviral drug combinations57
Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses55
Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models53
Investigating the virulence of coxsackievirus B6 strains and antiviral treatments in a neonatal murine model52
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication52
A proof-of-concept study for the efficacy of dispirotripiperazine PDSTP in a rabbit model of herpes simplex epithelial keratitis51
Caffeic acid phenethyl ester: an effective antiviral agent against porcine reproductive and Respiratory Syndrome Virus49
Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment45
Increased ILT2 expression contributes to dysfunction of CD56dimCD16+NK cells in chronic hepatitis B virus infection43
Editorial Board42
Editorial Board39
Evaluation of panel of neutralising murine monoclonal antibodies and a humanised bispecific antibody against influenza A(H1N1)pdm09 virus infection in a mouse model38
A safe replication-defective Zika virus vaccine protects mice from viral infection and vertical transmission38
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants34
Editorial Board33
New therapeutic perspective in the prevention of congenital cytomegalovirus infection33
Editorial Board33
Paxlovid for hospitalized COVID-19 patients with chronic kidney disease33
Meeting report: 36th International Conference on Antiviral Research in Lyon, France – March 13–17, 202331
Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response31
Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent31
Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD130
Editorial Board29
Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner29
Broad-spectrum antiviral diazadispiroalkane core molecules block attachment and cell-to-cell spread of herpesviruses29
0.039608001708984